Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 7

A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis

Total article views   HTML views PDF downloads Totals
12,606 Dovepress* 11,286+ 2,583 13,869
PubMed Central* 1,320 364 1,684
Totals 12,606 2,947 15,553
*Since 7 April 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar